03
Feb
2012
31
Jan
2012
17
Oct
2011
28
Jul
2011
27
Jul
2011
Posted in I - Series A, Q - 2Q11, R - MID WEST, X - CNS, X - Depression, XX - IL
Naurex (Evanston, IL) a clinical-stage pharmaceutical company focused on depression and other CNS-related disorders, closed a $18M Series A financing. Participants include Adams Street Partners, Latterell Venture Partners, Druid BioVentures, Genesys Capital, PathoCapital, Lundbeck, Takeda Ventures and Shire.
26
Jul
2011
19
May
2011
13
Apr
2011
Posted in I - Series C, Q - 1Q11, R - WEST, X - CNS, X - Cardiology, XX - CA
NextWave Pharmaceuticals (Cupertino, CA) a clinical-stage specialty pharmaceutical focused on cardiovascular and CNS diseases, closed a $45M Series C financing. Participants include Panorama Capital, Bay City Capital, Kearny Venture Partners, Aisling Capital, Fidelity Biosciences, Sofinnova Ventures and Vivo Ventures.
18
Jan
2011
Posted in I - Series A, Q - 4Q10, R - NORTH WEST, X - CNS, X - Metabolism, X - Oncology, XX - WA
Acylin Therapeutics (Seattle, WA) a development-stage biopharma company focused on inhibiting histone acetyltransferase in cancer, metabolic disease, and neurodegeneration indications, closed a $4.4M Series F financing. Participants include Alexandria Real Estate Equities, Amgen Ventures, ARCH Venture Partners, OVP Venture Partners, PPD and Washington Research Foundation Capital.
11
Jan
2011
16
Nov
2010
25
Oct
2010
20
Aug
2010